Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 100   

Articles published

SLXP 117.20 -1.25 (-1.06%)
price chart
Market Chatter: Paulson & Co. Takes An Undisclosed Stake In Salix ...
Hedge fund Paulson & Co. has taken up a stake in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), after the specialty pharmaceutical company announced it plans to recover from inventory-related issues by the end of next year, people close to the matter told ...
Credit Suisse Raises Salix Pharmaceuticals Price Target  Benzinga
Salix Pharmaceuticals Ltd. (SLXP) Is Rising On Inventory Reduction Plan  Nasdaq
Related articles »  
Piper Jaffray Reiterates ´┐ŻOverweight´┐Ż Rating On Salix Pharmaceuticals (SLXP)
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) seems to be getting back some of its lost credibility after the company announced it will be resolving its inventory problems earlier than expected.
Salix Pharmaceuticals Ltd. (SLXP) Jumped On Inventory Reduction Plans
Salix Pharmaceuticals Ltd. (SLXP: Quote) withdrew its previously-issued financial guidance for the fourth quarter as well as fiscal 2014 Tuesday morning, due to its decision to accelerate the reduction of wholesaler inventory levels and sell minimal ...
Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November
What: Shares of Salix Pharmaceuticals (NASDAQ: SLXP ) , a biopharmaceutical company that develops and acquires drugs designed to treat gastrointestinal diseases, was clobbered in November and fell by 29%, based on data from S&P Capital IQ, after the ...
Salix Pharmaceuticals Given Average Rating of "Hold" by Analysts ...  WKRB News
Related articles »  
Stock in Focus: Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)
Taking a look at the company's recent performance, Salix Pharmaceuticals, Ltd. (SLXP) reported third quarter earnings for fiscal year 2014 on November 06.
Morning Buzz: Cyclacel Pharmaceuticals, Inc. (CYCC), Salix Pharmaceuticals ...
Salix Pharmaceuticals Ltd. (SLXP) shares ticking higher following news that the company is working cooperatively with its principal pharmaceutical wholesalers to clear out its wholesaler inventory, just months after a potential acquisition stalled ...
Related articles »  
Analyst Upgrades: CVS Health Corp, Salix Pharmaceuticals, Ltd., and VeriFone ...
Analysts are weighing in today on pharmacy chain CVS Health Corp (NYSE:CVS), drug developer Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), and electronic payments facilitator VeriFone Systems Inc (NYSE:PAY). Here's a quick roundup of today's bullish ...
Stock Watch: Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)
[The Fly] Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that on December 15, 2014, the FDA provided written notice to the company that it has extended the Prescription Drug User Fee Act Action Date for XIFAXAN 550 for the treatment of irritable ...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) Up 8% - Cutting Wholesaler ...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) gains Tuesday after saying it has made steps to reduce wholesaler inventory levels of its drugs XIFAXAN 550, APRISO and UCERIS to a target of three months by the end of 2015.
Salix Pharmaceuticals To Reduce Inventory Earlier Than Expected
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has announced it will limit sales of three of its drugs, namely Apriso, Uceris, and Xifaxan 550, to bring down excess inventory piled up with its wholesalers.